Prevention and treatment of oral adverse effects of antiresorptive medications for osteoporosis - A position paper of the Brazilian Society of Endocrinology and Metabolism (SBEM), Brazilian Society of Stomatology and Oral Pathology (Sobep), and Brazilian Association for Bone Evaluation and Osteometabolism (Abrasso).


Journal

Archives of endocrinology and metabolism
ISSN: 2359-4292
Titre abrégé: Arch Endocrinol Metab
Pays: Brazil
ID NLM: 101652058

Informations de publication

Date de publication:
18 May 2021
Historique:
entrez: 25 5 2021
pubmed: 26 5 2021
medline: 28 5 2021
Statut: ppublish

Résumé

Antiresorptive therapy is the main form of prevention of osteoporotic or fragility fractures. Medication-related osteonecrosis of the jaw (MRONJ) is a relatively rare but severe adverse reaction to antiresorptive and antiangiogenic drugs. Physicians and dentists caring for patients taking these drugs and requiring invasive procedures face a difficult decision because of the potential risk of MRONJ. The aim of this study was to discuss the risk factors for the development of MRONJ and prevention of this complication in patients with osteoporosis taking antiresorptive drugs and requiring invasive dental treatment. For this goal, a task force with representatives from three professional associations was appointed to review the pertinent literature and discuss systemic and local risk factors, prevention of MRONJ in patients with osteoporosis, and management of established MRONJ. Although scarce evidence links the use of antiresorptive agents in the context of osteoporosis to the development of MRONJ, these agents are considered a risk factor for this complication. Despite the rare reports of MRONJ in patients with osteoporosis, the severity of symptoms and impact of MRONJ in the patients' quality of life make it imperative for health care professionals to consider this complication when planning invasive dental procedures.

Identifiants

pubmed: 34033275
pii: 2359-3997000000301
doi: 10.20945/2359-3997000000301
pmc: PMC10528626
doi:
pii:

Substances chimiques

Bone Density Conservation Agents 0
Diphosphonates 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

664-672

Références

Int J Oral Maxillofac Surg. 2012 Nov;41(11):1397-403
pubmed: 22840716
J Oral Maxillofac Surg. 2003 Sep;61(9):1115-7
pubmed: 12966493
Br J Oral Maxillofac Surg. 2016 Oct;54(8):930-935
pubmed: 27418080
J Oral Maxillofac Surg. 2009 Jun;67(6):1167-73
pubmed: 19446200
Oral Radiol. 2019 May;35(2):159-170
pubmed: 30484213
Oral Surg Oral Med Oral Pathol Oral Radiol. 2015 May;119(5):584-92
pubmed: 25864820
Osteoporos Int. 2016 May;27(5):1887-96
pubmed: 26626187
Osteoporos Int. 2009 Mar;20(3):399-408
pubmed: 18597037
J Clin Densitom. 2017 Jan - Mar;20(1):8-24
pubmed: 27956123
J Bone Miner Res. 2014 Jun;29(6):1363-8
pubmed: 24443366
J Clin Oncol. 2008 Aug 20;26(24):4037-8
pubmed: 18711196
EPMA J. 2019 Jan 24;10(1):21-29
pubmed: 30984311
J Oral Maxillofac Surg. 2014 Oct;72(10):1938-56
pubmed: 25234529
J Bone Miner Res. 2016 Jan;31(1):16-35
pubmed: 26350171
Oral Oncol. 2012 Sep;48(9):817-21
pubmed: 22483860
J Oral Maxillofac Surg. 2004 May;62(5):527-34
pubmed: 15122554
Mayo Clin Proc. 2008 Sep;83(9):1032-45
pubmed: 18775204
J Clin Endocrinol Metab. 2005 Mar;90(3):1294-301
pubmed: 15598694
J Oral Maxillofac Surg. 2007 Dec;65(12):2397-410
pubmed: 18022461
Maxillofac Plast Reconstr Surg. 2018 Jul 05;40(1):17
pubmed: 30038904
J Craniomaxillofac Surg. 2015 Jul;43(6):847-54
pubmed: 25958767
Bone. 2017 Dec;105:11-17
pubmed: 28789921
Int J Oral Maxillofac Surg. 2015 Dec;44(12):1558-64
pubmed: 26304604
J Bone Miner Res. 2015 Jan;30(1):3-23
pubmed: 25414052
Oral Dis. 2019 Oct;25(7):1815-1821
pubmed: 31325201
J Med Econ. 2019 Jul;22(7):638-644
pubmed: 30835577
J Craniofac Surg. 2016 May;27(3):697-701
pubmed: 27092912
Med Oral Patol Oral Cir Bucal. 2016 Mar 01;21(2):e250-9
pubmed: 26827065
J Bone Miner Metab. 2017 Jan;35(1):6-19
pubmed: 28035494
Am J Orthod Dentofacial Orthop. 2007 Mar;131(3):321-6
pubmed: 17346586
J Clin Exp Dent. 2017 Jan 1;9(1):e141-e149
pubmed: 28149479
Oral Dis. 2019 Mar;25(2):471-480
pubmed: 30153366
Maturitas. 2017 Jul;101:23-30
pubmed: 28539165
Lancet Diabetes Endocrinol. 2017 Jul;5(7):513-523
pubmed: 28546097
J Bone Miner Metab. 2020 Jan;38(1):126-134
pubmed: 31410544
Am J Orthod Dentofacial Orthop. 2009 Mar;135(3):361-74
pubmed: 19268836
Gerodontology. 2016 Jun;33(2):155-60
pubmed: 24698332
J Clin Periodontol. 2015 Oct;42(10):922-32
pubmed: 26362756
J Endod. 2009 Nov;35(11):1525-8
pubmed: 19840641
Support Care Cancer. 2020 May;28(5):2265-2271
pubmed: 31468192
Int J Implant Dent. 2016 Dec;2(1):9
pubmed: 27747701
J Craniomaxillofac Surg. 2016 Dec;44(12):1945-1951
pubmed: 27836551
Calcif Tissue Int. 2013 Sep;93(3):241-8
pubmed: 23756612
Rev Bras Reumatol Engl Ed. 2017;57 Suppl 2:452-466
pubmed: 28838768
Cleve Clin J Med. 2011 Sep;78(9):619-30
pubmed: 21885695
Am J Med. 2013 Jan;126(1):13-20
pubmed: 23177553
J Oral Maxillofac Surg. 2010 May;68(5):959-63
pubmed: 20149510
Clin Oral Implants Res. 2016 Aug;27(8):943-9
pubmed: 26178697
J Craniofac Surg. 2015 May;26(3):749-55
pubmed: 25974785
Osteoporos Int. 2017 Aug;28(8):2465-2473
pubmed: 28451732
Oral Surg Oral Med Oral Pathol Oral Radiol. 2019 Feb;127(2):117-135
pubmed: 30393090
Med Oral Patol Oral Cir Bucal. 2019 Jan 1;24(1):e26-e36
pubmed: 30595601
Oral Radiol. 2018 May;34(2):151-160
pubmed: 30484130
Int J Oral Maxillofac Surg. 2015 Jul;44(7):840-4
pubmed: 25861974
Oral Surg Oral Med Oral Pathol Oral Radiol. 2014 Aug;118(2):202-8
pubmed: 25047929
Arq Bras Endocrinol Metabol. 2014 Mar;58(2):162-71
pubmed: 24830593
Osteoporos Int. 2017 Oct;28(10):2921-2928
pubmed: 28664276
J Evid Based Dent Pract. 2016 Jun;16(2):136-8
pubmed: 27449847
J Am Dent Assoc. 2019 Aug;150(8):664-675.e8
pubmed: 31256803
J Bone Miner Res. 2017 Dec;32(12):2445-2452
pubmed: 28815779
J Stomatol Oral Maxillofac Surg. 2020 Feb;121(1):84-89
pubmed: 30794883
J Oral Maxillofac Surg. 2014 Aug;72(8):1456-62
pubmed: 24793621
Imaging Sci Dent. 2017 Mar;47(1):45-50
pubmed: 28361029

Auteurs

Miguel Madeira (M)

Divisão de Endocrinologia, Departamento de Clínica Médica, Hospital Universitário Clementino Fraga Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brasil, migmadeira@gmail.com.
Divisão de Endocrinologia, Departamento de Clínica Médica, Hospital Federal de Bonsucesso, Rio de Janeiro, RJ, Brasil.

André Caroli Rocha (AC)

Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo, São Paulo, SP, Brasil.

Carolina Aguiar Moreira (CA)

Unidade de Endocrinologia e Metabologia (SEMPR), Universidade Federal do Paraná, Curitiba, PR, Brasil.

Águida Maria Menezes Aguiar (ÁMM)

Hospital Municipal Souza Aguiar, Secretaria Municipal de Saúde do Rio de Janeiro, Rio de Janeiro, RJ, Brasil.

Sergio Setsuo Maeda (SS)

Disciplina de Endocrinologia, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, SP, Brasil.

Abel Silveira Cardoso (AS)

Departamento de Patologia e Diagnóstico Oral, Faculdade de Odontologia, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brasil.

Charlles Heldan de Moura Castro (CH)

Divisão de Reumatologia, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, SP, Brasil.

Catarina Brasil D'Alva (CB)

Departamento de Medicina Clínica, Universidade Federal do Ceará, Fortaleza, CE, Brasil.

Barbara Campolina Carvalho Silva (BCC)

Faculdade de Medicina, Centro Universitário de Belo Horizonte, Belo Horizonte, MG, Brasil.
Divisão de Endocrinologia, Hospital Felício Rocho, Belo Horizonte, MG, Brasil.
Divisão de Endocrinologia, Santa Casa de Belo Horizonte, Belo Horizonte, MG, Brasil.

Bruno Ferraz-de-Souza (B)

Laboratório de Endocrinologia Celular e Molecular (LIM-25) e Unidade de Doenças Osteometabólicas, Divisão de Endocrinologia, Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brasil.

Marise Lazaretti-Castro (M)

Disciplina de Endocrinologia, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, SP, Brasil.

Francisco Bandeira (F)

Divisão de Endocrinologia e Diabetes, Faculdade de Medicina da Universidade de Pernambuco, Recife, PE, Brasil.

Sandra R Torres (SR)

Departamento de Patologia e Diagnóstico Oral, Faculdade de Odontologia, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brasil.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH